CA-17-QL18_10uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=10uM, (2S)-4-cyclohexyl-2-[[1-[(4-nitrophenyl)methyl]-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]amino]butanoic acid, Angiotensin AT2 Antagonists targeting AGTR2 (Novartis, 22878749)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/22878749
Similar Terms
Downloads & Tools

Genes

4 genes differentially expressed following the CA-17-QL18_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
OAZ1 ornithine decarboxylase antizyme 1 0.240335

decreased expression

Symbol Name Standardized Value
C15ORF38-AP3S2 C15orf38-AP3S2 readthrough -0.313316
STAU1 staufen double-stranded RNA binding protein 1 -0.238852
FXR1 fragile X mental retardation, autosomal homolog 1 -0.219392